These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24577514)

  • 1. Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.
    Singer ST; Kuypers F; Fineman J; Gildengorin G; Larkin S; Sweeters N; Rosenfeld H; Kurio G; Higa A; Jeng M; Huang J; Vichinsky EP
    Ann Hematol; 2014 Jul; 93(7):1139-48. PubMed ID: 24577514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis.
    Srihirun S; Tanjararak N; Chuncharunee S; Sritara P; Kaewvichit R; Fucharoen S; Pattanapanyasat K; Sibmooh N
    Thromb Res; 2015 Jan; 135(1):121-6. PubMed ID: 25455999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
    Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric dimethylarginine levels in children with β-thalassemia and their correlations to tricuspid regurgitant jet velocity.
    Mohamed el-S; Ibrahim B; Amr D; Noha el-K; Mokhtar M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1540-3. PubMed ID: 24753210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.
    Morris CR; Kim HY; Trachtenberg F; Wood J; Quinn CT; Sweeters N; Kwiatkowski JL; Thompson AA; Giardina PJ; Boudreaux J; Olivieri NF; Porter JB; Neufeld EJ; Vichinsky EP;
    Blood; 2011 Oct; 118(14):3794-802. PubMed ID: 21772051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in well-transfused thalassemia major patients.
    Meloni A; Detterich J; Pepe A; Harmatz P; Coates TD; Wood JC
    Blood Cells Mol Dis; 2015 Feb; 54(2):189-94. PubMed ID: 25488617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Hypertension in Children With β Thalassemia Major, Are Splenectomy and High-Ferritin Levels Related or Not?
    Dedeoglu S; Bornaun H
    J Pediatr Hematol Oncol; 2017 May; 39(4):259-265. PubMed ID: 28234742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia.
    Sinha AA; Adusumilli T; Cohen HW; Nouraie M; Little J; Manwani D
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27928. PubMed ID: 31322833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
    Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
    Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.
    Minniti CP; Sable C; Campbell A; Rana S; Ensing G; Dham N; Onyekwere O; Nouraie M; Kato GJ; Gladwin MT; Castro OL; Gordeuk VR
    Haematologica; 2009 Mar; 94(3):340-7. PubMed ID: 19211639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.
    Uaprasert N; Satitthummanid S; Akkawat B; Sutcharitchan P; Rojnuckarin P
    Thromb Res; 2019 Feb; 174():104-112. PubMed ID: 30584959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.
    Agha H; El Tagui M; El Ghamrawy M; Abdel Hady M
    Ann Hematol; 2014 Jul; 93(7):1131-8. PubMed ID: 24562420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.
    El-Shanshory M; Badraia I; Donia A; Abd El-Hameed F; Mabrouk M
    Eur J Haematol; 2013 Jul; 91(1):55-61. PubMed ID: 23551575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.
    Desai PC; May RC; Jones SK; Strayhorn D; Caughey M; Hinderliter A; Ataga KI
    Br J Haematol; 2013 Sep; 162(6):836-41. PubMed ID: 23829561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.
    Liem RI; Young LT; Thompson AA
    Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
    Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
    Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.
    Rai P; Joshi VM; Goldberg JF; Yates AM; Okhomina VI; Penkert R; Ataga KI; Kang G; Hankins JS
    Blood Adv; 2021 Jan; 5(1):89-98. PubMed ID: 33570630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.
    Armstrong GT; Joshi VM; Zhu L; Srivastava D; Zhang N; Ness KK; Stokes DC; Krasin MT; Fowler JA; Robison LL; Hudson MM; Green DM
    J Clin Oncol; 2013 Feb; 31(6):774-81. PubMed ID: 23295810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.
    Detterich JA; Kato RM; Rabai M; Meiselman HJ; Coates TD; Wood JC
    Blood; 2015 Aug; 126(6):703-10. PubMed ID: 26036801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.